ES2058931T3 - Un reactivo para la deteccion de actividad fibrinolitica. - Google Patents

Un reactivo para la deteccion de actividad fibrinolitica.

Info

Publication number
ES2058931T3
ES2058931T3 ES90912800T ES90912800T ES2058931T3 ES 2058931 T3 ES2058931 T3 ES 2058931T3 ES 90912800 T ES90912800 T ES 90912800T ES 90912800 T ES90912800 T ES 90912800T ES 2058931 T3 ES2058931 T3 ES 2058931T3
Authority
ES
Spain
Prior art keywords
antibody
fibrinolytic
detection
enzyme
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90912800T
Other languages
English (en)
Inventor
Johan Selmer
Niels Tromholt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2058931T3 publication Critical patent/ES2058931T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972Plasminogen activators
    • G01N2333/9726Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

UN REACTIVO DE DIAGNOSTICO PARA LA DETECCION IN VIVO DE UNA LIBERACION AUMENTADA DE UNA ENZIMA FIBRINOLITICA O DE UNA ACTIVIDAD FIBRINOLITICA AUMENTADA EN EL CUERPO HUMANO O DE ANIMALES QUE CONTIENE UN REACTIVO DE ANTICUERPO A UNA ENZIMA FRIBINOLITICA O UN FRAGMENTO DEL ANTICUERPO, MARCADO CON UNA SUSTANCIA QUE PERMITE LA DETECCION IN VIVO DEL ENLACE DEL ANTICUERPO A LA ENZIMA FIBRINOLITICA. EN UNA PUESTA EN PRACTICA DE LA INVENCION, LA SEPARACION AUMENTADA DEL ANTICUERPO ES PROPORCIONADA MEDIANTE LA ADMINISTRACION SUBSIGUIENTE DE LA ENZIMA FIBRINOLITICA A LA QUE ES REACTIVO EL ANTICUERPO. LA ENZIMA FIBRINOLITICA ES PREFERENTEMENTE T-PA.
ES90912800T 1989-08-18 1990-08-16 Un reactivo para la deteccion de actividad fibrinolitica. Expired - Lifetime ES2058931T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens

Publications (1)

Publication Number Publication Date
ES2058931T3 true ES2058931T3 (es) 1994-11-01

Family

ID=8129992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90912800T Expired - Lifetime ES2058931T3 (es) 1989-08-18 1990-08-16 Un reactivo para la deteccion de actividad fibrinolitica.

Country Status (18)

Country Link
US (1) US5165912A (es)
EP (1) EP0487594B1 (es)
JP (1) JPH04507254A (es)
KR (1) KR920703120A (es)
AT (1) ATE92770T1 (es)
AU (1) AU639940B2 (es)
CA (1) CA2065147A1 (es)
CZ (1) CZ280904B6 (es)
DD (1) DD297064A5 (es)
DE (1) DE69002769T2 (es)
DK (2) DK408289D0 (es)
ES (1) ES2058931T3 (es)
FI (1) FI920669A0 (es)
IE (1) IE65525B1 (es)
IL (1) IL95407A (es)
NO (1) NO920624L (es)
NZ (1) NZ234937A (es)
WO (1) WO1991002546A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
MX2010013282A (es) * 2008-06-04 2010-12-21 Talecris Biotherapeutics Inc Composicion, metodo y kit para la preparacion de plasmina.
PL2403865T3 (pl) 2009-03-03 2016-01-29 Grifols Therapeutics Inc Sposoby wytwarzania plazminogenu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169232B1 (en) * 1984-01-23 1990-04-25 For Energiteknikk Institutt Composition for technetium-99m labelling of proteinaceous material
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
CA1285223C (en) * 1986-11-10 1991-06-25 New England Deaconess Hospital Detection of vascular disease

Also Published As

Publication number Publication date
ATE92770T1 (de) 1993-08-15
AU6285990A (en) 1991-04-03
CZ404790A3 (en) 1996-01-17
FI920669A0 (fi) 1992-02-17
CZ280904B6 (cs) 1996-05-15
NO920624D0 (no) 1992-02-17
KR920703120A (ko) 1992-12-17
IL95407A (en) 1994-07-31
JPH04507254A (ja) 1992-12-17
US5165912A (en) 1992-11-24
DK0487594T3 (da) 1994-01-03
CA2065147A1 (en) 1991-02-19
NO920624L (no) 1992-02-17
AU639940B2 (en) 1993-08-12
DE69002769D1 (de) 1993-09-16
DD297064A5 (de) 1992-01-02
DE69002769T2 (de) 1993-12-02
EP0487594B1 (en) 1993-08-11
EP0487594A1 (en) 1992-06-03
IL95407A0 (en) 1991-06-30
DK408289D0 (da) 1989-08-18
NZ234937A (en) 1991-11-26
WO1991002546A1 (en) 1991-03-07
IE65525B1 (en) 1995-11-01
IE902977A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
NZ253294A (en) Extraction of prothrombin from blood
ES2065303T3 (es) Procedimiento de diagnosis y vacuna especifica.
ES2035847T3 (es) Un procedimiento para la elaboracion de una preparacion farmaceutica.
UA6035A1 (uk) Засіб для визначення лейкоцітів в сечі
ES2058931T3 (es) Un reactivo para la deteccion de actividad fibrinolitica.
DK180682A (da) Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt
DK369287A (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
ES2184901T3 (es) Anticuerpos anti-idiotipicos del factor de crecimiento endotelial vascular y su utilizacion como medicamentos.
ES2075835T3 (es) Correccion con arn de doble cadena de una insuficiencia en la arnasa l.
AR004093A1 (es) El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas.
ES2047017T3 (es) Agente de separacion acuoso para la produccion de cuerpos moldeados de poliuretano.
DE3585049D1 (de) Monoklonale antikoerper.
FI881122A0 (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
DK112290D0 (da) Vaevsplasminogenaktivator-variant
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ZA897586B (en) Antidote
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
ES550932A0 (es) Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.
AR240063A1 (es) Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135.
FR2205571A1 (en) Viral disease diagnosis - with antigen from incubated erythrocytes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 487594

Country of ref document: ES